What TMMC does

TMMC (株式会社ＴＭＭＣ) is a Tokyo-based private Japanese corporation founded in 2006 that operates two distinct business lines anchored in healthcare and environmental materials. Its primary Healthcare IT division delivers a suite of BRMS-based (Business Rule Management System) products using forward-chaining rule-based inference, including the Meri automated medical receipt (レセプト) inspection system, a receipt enhancement inspection system that categorizes billing opportunities into four classes (A–D), a medication information sharing system for cross-institution prescription checks, and a disaster medical information sharing system developed jointly with Toho University Medical Center Omori Hospital. Beyond software, TMMC runs hospital management consulting engagements on a pure performance-based fee model — the firm absorbs financial risk and is paid only after delivering measurable results, which it quantifies as an average 1.3% improvement in medical revenue ratio over a five-year window — and provides outsourced 保険者点検 (insurer inspection) services to corporate health insurance associations using the same Meri engine.

The company also operates an eco-materials business through subsidiary Crossroad Inc., importing and distributing CBCM and MiCb fully biodegradable composite materials developed in partnership with Fujian Xindi New Materials Technology Co., Ltd. of China. These materials target plastic replacement across medical supplies, agricultural films, packaging, construction, and textiles, with a patent application (特願2023-130818) pending for the MiCb variant.

TMMC's go-to-market is sales-led and entirely domestic to Japan, targeting hospitals, health insurance associations, and medical professional associations (physician, pharmacist, dentist) through direct enterprise outreach, free trial data analyses, referral networks, and participation in disaster preparedness drills. Customer base exceeds 100 organizations including named logos such as St. Luke's International Hospital, Niigata Prefectural 13 Hospitals, Sapporo Medical University Hospital, Aisin Seiki Health Insurance Association, Fujitsu Health Insurance Association, and Hitachi Health Insurance Association. The company maintains a Privacy Mark certification in the healthcare and welfare domain (renewed eight times since 2009, valid through March 2025) and received the 14th Chiyoda Business Award Excellence Award in 2023.

Name

TMMC

Legal name

株式会社ＴＭＭＣ

Website

https://tmmcon.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Others

Revenue model

1. Hospital Consulting — Performance-Based Fees: TMMC's hospital consulting business operates on a pure performance-based fee model (完全成果報酬型). Financial impact is borne by TMMC, not the client. The company delivers measurable medical revenue improvement (1.3% average increase in medical revenue ratio over 5 years). Fees are paid after performance results are realized, minimizing client financial risk. Fixed fees are also available upon request.
2. Insurance Review Outsourcing Services: TMMC provides outsourced insurance claim (レセプト) inspection services to health insurance associations using its Meri system. Services include single-month medical and dispensing receipt inspections, cross-month vertical inspections, and combined medical-dispensing cross-referencing. Revenue is generated through service fees for the inspection outsourcing.
3. Software Licensing — Meri System Sales: The Meri automated inspection system is sold as a licensed software product. Sales of the Meri system began in May 2011. Revenue is generated through software licensing fees to healthcare organizations.
4. Biodegradable Materials Sales (CBCM/MiCb): TMMC, in partnership with Fujian Xindi New Materials Technology Co., Ltd. via subsidiary Crossroad Inc., plans to manufacture and sell CBCM/MiCb fully biodegradable composite materials. Currently imports and stocks 16 types of CBCM pellets from China for domestic sales. Products are targeted for medical supplies, agricultural films, packaging, construction materials, textiles, and consumer goods.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

TMMC delivers hospital management consulting using its proprietary BRMS-based Meri automated receipt inspection system to identify missed billing (増点) opportunities and improve medical revenue ratios. It also outsources insurance claim (レセプト) inspection services to health insurance associations and distributes fully biodegradable composite materials (CBCM/MiCb) as plastic alternatives through its subsidiary Crossroad Inc.

Product overview

TMMC operates as a multi-business company with two main divisions: (1) Medical/Healthcare IT Solutions comprising four integrated systems under the Meri platform family — the automated receipt inspection system Meri, the receipt increase-point inspection system, the medication information sharing system, and the disaster medical information sharing system — plus hospital consulting and insurance examiner inspection services; and (2) an eco-friendly materials business developing and selling CBCM and MiCb fully biodegradable composite new materials as plastic alternatives for various applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Consulting Service (病院コンサル事業) Performance-based hospital management consulting that uses the proprietary Meri receipt inspection system to identify missed billing (増点) opportunities. Delivered through a dialogue-oriented collaborative approach with quantifiable revenue improvement, averaging a 1.3% increase in medical revenue ratio over five years. Engagements begin with a free trial data analysis on the most recent month's (or two months for first engagement) receipt data, and include a 24-month monitoring program with standardized manuals. Targeted at hospital management teams seeking measurable revenue improvement.
• Insurance Examiner Inspection Service (保険者点検事業) Outsourced insurance claim (レセプト) inspection services for health insurance associations using the Meri automated inspection system. Covers single-month medical and dispensing receipt inspections, cross-month vertical inspections, and combined medical-dispensing cross-referencing. Sold to corporate and trade health insurance associations in Japan seeking high-accuracy, scalable claim review.
• Meri Automated Receipt Inspection System (レセプト自動点検システム Meri) Proprietary software built on a Business Rule Management System (BRMS) with forward-chaining inference for automated medical billing receipt inspection. Combines automated inspection with conversational inspection modes for high-accuracy verification of medical claims. Sold as licensed software to healthcare organizations.
• Receipt Enhancement Inspection System (レセプト増点点検システム) Software that inherits the philosophy of the Meri system to analyze potential billing enhancement (増点) opportunities in medical claims. Classifies each inspection target into four categories: A (billing possible), B (higher-point billing possible), C (confirmation needed), D (improvement enables future billing). Helps hospitals identify missed revenue opportunities.
• Medication Information Sharing System (お薬情報共有システム) Platform where dispensing pharmacies upload dispensing receipt data to a dedicated server to auto-generate patient medication records (お薬手帳). Member hospitals, clinics, and dispensing pharmacies can flexibly search patient medication records for prescription checks and medication guidance. Also serves as a disaster medical information coordination tool.
• Disaster Medical Information Sharing System (災害時医療情報共有システム) Disaster medical information sharing system developed in joint research with Toho University Medical Center Omori Hospital. Enables real-time simultaneous information updates across departments and external organizations using an internet and Excel-based system during disaster scenarios.
• CBCM/MiCb Fully Biodegradable Composite Materials (脱プラスチック事業) Fully biodegradable composite materials for plastic replacement. CBCM uses bamboo, shell, starch, and biodegradable polymers (PBAT, PBS, PLA); MiCb adds titanium, silver, copper, vanadium, and surfactants for antibacterial, deodorizing, anti-mold, anti-viral, negative-ion generation, and other functions. Currently 16 CBCM pellet variants imported from China and sold domestically for medical supplies, agricultural films, packaging, construction, textiles, and consumer goods applications. Compatible with existing plastic manufacturing equipment.

Quantifiable outcome

• 1.3% average improvement in medical revenue ratio over 5 years of consulting engagements
• +2 more outcomes

Named customers15 records

Segments1 record

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• 福建新迪新材料科技有限公司 (Fujian Xindi New Materials Technology Co., Ltd.)coreTechnology or Integration · 1 January 2019Fujian Xindi New Materials Technology Co., Ltd. is a Chinese company that developed the CBCM fully biodegradable composite material in 2019. TMMC's subsidiary Crossroad Inc. (株式会社クロスロード) entered into a full equipment and know-how import contract, making TMMC the official Japanese contact for CBCM/MiCb materials. TMMC imports CBCM pellets (16 variants) from this partner for domestic distribution in Japan.
• 株式会社クロスロード (Crossroad Inc.)coreStrategic or Co-development Partner · 1 January 2019TMMC partnered with its subsidiary Crossroad Inc. to serve as the official Japanese representative and licensee for the CBCM/MiCb fully biodegradable materials technology. Crossroad Inc. handles the equipment and know-how import and domestic business development for the de-plastic business segment.
• 有限責任監査法人トーマツ (Deloitte Touche Tohmatsu LLC)minorImplementation/ SI/ Consulting PartnerListed as a partner company (パートナー企業) in TMMC's corporate information.
• 東邦大学医療センター大森病院 (Toho University Medical Center Omori Hospital)coreStrategic or Co-development PartnerTMMC conducts joint research (共同研究) with Toho University Medical Center Omori Hospital on disaster medical information sharing systems. The collaboration involves using internet and Excel-based real-time simultaneous information updates across hospital departments and external organizations during disaster scenarios.
• 大田区大森医師会 / 大田区フォリオ会 (Omori Medical Association / Ota-ku Pharmaceutical Association)coreStrategic or Co-development PartnerTMMC developed its medication information sharing system with the support and cooperation of the Omori Medical Association and Ota-ku Pharmaceutical Association. These organizations participated in disaster preparedness drills using the system, confirming medication information coordination during triage in emergency scenarios.
• 株式会社フェレンカ (Ferenka Inc.)minorStrategic or Co-development PartnerTMMC is the comprehensive sales contact for food additive FRe and FR-X related business, jointly promoted with Ferenka Inc. (関係会社フェレンカ). Ferenka is a related company in the food additive development business. TMMC has issued a fraud warning about unauthorized use of their company name in FRe/FR-X sales activities.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Medical Data Vision Co., Ltd. Japanese healthcare data and analytics company that aggregates and analyzes medical receipt (レセプト) and DPC data for hospitals, insurers, and pharma. Closely comparable to TMMC in working with receipt data and serving Japanese health insurance associations and hospitals, but at a much larger scale.
• JMDC Inc. Japanese healthcare data analytics company built on receipt (レセプト) and claims databases serving insurers, pharma, and providers. Highly comparable to TMMC's insurance-review-outsourcing business and receipt-based analytics, though JMDC focuses on data aggregation rather than inspection workflow.
• EM Systems Co., Ltd. (now e-Healthcare Inc.): Japanese vendor of medical billing and electronic medical record software for clinics and hospitals, including receipt (レセプト) processing. The most direct functional peer to TMMC's Meri system within the Japanese medical-billing software category.
• ARIA Co., Ltd. Japanese provider of electronic medical record and receipt (レセプト) software solutions to hospitals and clinics. Directly comparable to TMMC's medical billing software footprint in the Japanese market.

Broad incumbents

• M3, Inc. Large Japanese medical internet platform serving physicians, pharma, and providers via m3.com and adjacent services. Overlaps with TMMC in targeting Japanese healthcare decision-makers but operates at much greater scale and breadth.
• Fujitsu Limited: Large Japanese IT conglomerate with healthcare offerings spanning electronic medical records, regional medical coordination systems, and hospital IT. Comparable to TMMC in serving Japanese hospitals and health insurers, but as part of a much broader portfolio and at global scale.
• NTT DATA Group Corporation: Major Japanese IT services group with a dedicated healthcare business covering medical information systems, regional medical coordination, and insurance systems. Comparable to TMMC in targeting Japanese hospitals and health insurance associations but at significantly larger scale.
• Health Catalyst, Inc. US-based healthcare data and analytics platform that helps hospitals and health systems improve operational and financial performance. Comparable to TMMC's hospital revenue-improvement value proposition, though at much larger scale and serving US providers.
• Premier, Inc. US healthcare performance improvement company offering consulting, analytics, and group-purchasing services to hospitals and health systems. Comparable to TMMC's hospital consulting and performance-improvement model, but US-focused and far larger.
• Vizient, Inc. US healthcare performance improvement and analytics firm serving hospitals and health systems with consulting, benchmarking, and supply-chain optimization. Comparable to TMMC's hospital revenue-improvement consulting approach, though operating in the US market at much greater scale.

Market position

Strengths5 records

Weaknesses6 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TMMC